Motivation: Multiple sclerosis lesions contribute to progression of disability. Spinal cord lesions are of particular importance due to the small cross-sectional area of the cord and presence of important tracts. Goal(s): Determine if myelin damage in lesions could be used as a potential prognostic biomarker of disease progression. Approach: Use myelin water imaging to determine myelin content in lesional, perilesional and white matter tissue, and correlate with change in clinical tests over 5 years. Results: We determine a gradient of myelin damage beyond what is visible on conventional imaging. We strongly correlated myelin damage in the lesion and surrounding tissue to accrual of disability. Impact: Spinal cord myelin imaging of lesional and perilesional tissue may be useful as a prognostic biomarker for monitoring patients with progressive multiple sclerosis (MS) especially in clinical trials for progressive MS, for which therapies are lacking.
Johnson et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: